American National Insurance’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $666K | Hold |
12,000
| – | – | 0.18% | 167 |
|
|
2021
Q4 | $672K | Sell |
12,000
-100,000
| -89% | -$5.42M | 0.15% | 190 |
|
|
2021
Q3 | $5.38M | Hold |
112,000
| – | – | 0.2% | 141 |
|
|
2021
Q2 | $4.69M | Hold |
112,000
| – | – | 0.18% | 167 |
|
|
2021
Q1 | $3.78M | Hold |
112,000
| – | – | 0.15% | 179 |
|
|
2020
Q4 | $3.91M | Hold |
112,000
| – | – | 0.17% | 164 |
|
|
2020
Q3 | $3.89M | Hold |
112,000
| – | – | 0.19% | 135 |
|
|
2020
Q2 | $3.67M | Hold |
112,000
| – | – | 0.19% | 136 |
|
|
2020
Q1 | $3.37M | Hold |
112,000
| – | – | 0.22% | 125 |
|
|
2019
Q4 | $3.24M | Sell |
112,000
-12,000
| -10% | -$332K | 0.17% | 150 |
|
|
2019
Q3 | $3.21M | Hold |
124,000
| – | – | 0.17% | 151 |
|
|
2019
Q2 | $3.16M | Hold |
124,000
| – | – | 0.17% | 154 |
|
|
2019
Q1 | $3.24M | Hold |
124,000
| – | – | 0.17% | 157 |
|
|
2018
Q4 | $2.86M | Hold |
124,000
| – | – | 0.17% | 151 |
|
|
2018
Q3 | $2.92M | Hold |
124,000
| – | – | 0.14% | 163 |
|
|
2018
Q2 | $2.86M | Hold |
124,000
| – | – | 0.14% | 173 |
|
|
2018
Q1 | $3.05M | Hold |
124,000
| – | – | 0.16% | 169 |
|
|
2017
Q4 | $3.33M | Hold |
124,000
| – | – | 0.17% | 165 |
|
|
2017
Q3 | $2.98M | Hold |
124,000
| – | – | 0.16% | 165 |
|
|
2017
Q2 | $2.66M | Hold |
124,000
| – | – | 0.15% | 173 |
|
|
2017
Q1 | $2.13M | Hold |
124,000
| – | – | 0.12% | 189 |
|
|
2016
Q4 | $2.22M | Hold |
124,000
| – | – | 0.13% | 183 |
|
|
2016
Q3 | $2.58M | Hold |
124,000
| – | – | 0.15% | 180 |
|
|
2016
Q2 | $3.33M | Hold |
124,000
| – | – | 0.2% | 147 |
|
|
2016
Q1 | $3.36M | Hold |
124,000
| – | – | 0.2% | 145 |
|
|
2015
Q4 | $3.6M | Hold |
124,000
| – | – | 0.21% | 137 |
|
|
2015
Q3 | $3.36M | Hold |
124,000
| – | – | 0.21% | 139 |
|
|
2015
Q2 | $3.4M | Hold |
124,000
| – | – | 0.2% | 150 |
|
|
2015
Q1 | $3.31M | Hold |
124,000
| – | – | 0.2% | 154 |
|
|
2014
Q4 | $2.62M | Hold |
124,000
| – | – | 0.16% | 173 |
|
|
2014
Q3 | $2.95M | Hold |
124,000
| – | – | 0.18% | 165 |
|
|
2014
Q2 | $2.86M | Hold |
124,000
| – | – | 0.17% | 169 |
|
|
2014
Q1 | $2.83M | Hold |
124,000
| – | – | 0.18% | 164 |
|
|
2013
Q4 | $2.29M | Hold |
124,000
| – | – | 0.15% | 176 |
|
|
2013
Q3 | $2.1M | Hold |
124,000
| – | – | 0.15% | 176 |
|
|
2013
Q2 | $1.92M | Buy |
+124,000
| New | +$2.06M | 0.14% | 183 |
|
Other funds holding NVO
American National Insurance's NVO Position: Q1 2022 in Review
American National Insurance held its Novo Nordisk (NVO) position steady in Q1 2022 at 12,000 shares worth $666K. The position accounts for 0.18% of the portfolio, ranked #167.
American National Insurance first reported a position in NVO in Q2 2013 and has held it in 36 quarters since. The position peaked at $5.38M in Q3 2021. 902 funds tracked by Wall St. Rank hold NVO as of Q1 2022.
- American National Insurance held 12,000 shares of Novo Nordisk worth $666K as of Q1 2022.
- American National Insurance left its Novo Nordisk share count unchanged in Q1 2022.
- Novo Nordisk made up 0.18% of American National Insurance's portfolio in Q1 2022, its #167 holding.
- American National Insurance first reported a position in Novo Nordisk in Q2 2013 and has held it in 36 quarters since.
- American National Insurance's Novo Nordisk position peaked at $5.38M in Q3 2021.
- 902 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.